The profile of IGFBPs were first characterized in the synovial fluid of RA patients, in which IGFBP2, IGFBP3, and IGFBP4 levels were significantly elevated compared to normal individuals or osteoarthritis patients (71–74). This evidence concerns the gene IGFBP2 and rheumatoid arthritis.